Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1977 1
1980 4
1981 1
1982 3
1983 2
1986 1
1989 2
1990 2
1992 2
1993 1
1995 2
1996 3
1997 4
1998 3
1999 2
2000 2
2001 2
2002 3
2003 4
2004 4
2005 5
2006 3
2007 3
2009 2
2010 5
2011 9
2012 6
2013 9
2014 11
2015 8
2016 6
2017 7
2018 7
2019 11
2020 18
2021 9
2022 7
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Treatment for Mild Chronic Hypertension during Pregnancy.
Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, Gibson K, Haas DM, Plante L, Metz T, Casey B, Esplin S, Longo S, Hoffman M, Saade GR, Hoppe KK, Foroutan J, Tuuli M, Owens MY, Simhan HN, Frey H, Rosen T, Palatnik A, Baker S, August P, Reddy UM, Kinzler W, Su E, Krishna I, Nguyen N, Norton ME, Skupski D, El-Sayed YY, Ogunyemi D, Galis ZS, Harper L, Ambalavanan N, Geller NL, Oparil S, Cutter GR, Andrews WW; Chronic Hypertension and Pregnancy (CHAP) Trial Consortium. Tita AT, et al. N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2. N Engl J Med. 2022. PMID: 35363951 Free PMC article. Clinical Trial.
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS; VX17-445-103 Trial Group. Heijerman HGM, et al. Among authors: welter jj. Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31. Lancet. 2019. PMID: 31679946 Free PMC article. Clinical Trial.
Transforming the Activation of Clinical Trials.
Watters JT, Pitzen JH, Sanders LJ, Bruce VNM, Cornell AR, Cseko GC, Grace JS, Kwon PS, Kukla AK, Lee MS, Monosmith MD, Myren JD, Kottschade RS, Shaft MN, Weis JJA, Welter JC, Bharucha AE. Watters JT, et al. Among authors: welter jc. Clin Pharmacol Ther. 2018 Jan;103(1):43-46. doi: 10.1002/cpt.898. Epub 2017 Nov 6. Clin Pharmacol Ther. 2018. PMID: 29105757 Free PMC article.
The epidermis: genes on - genes off.
Eckert RL, Crish JF, Banks EB, Welter JF. Eckert RL, et al. Among authors: welter jf. J Invest Dermatol. 1997 Oct;109(4):501-9. doi: 10.1111/1523-1747.ep12336477. J Invest Dermatol. 1997. PMID: 9326381 Free article. Review.
n-3 Polyunsaturated Fatty Acids Modulate LPS-Induced ARDS and the Lung-Brain Axis of Communication in Wild-Type versus Fat-1 Mice Genetically Modified for Leukotriene B4 Receptor 1 or Chemerin Receptor 23 Knockout.
Hernandez J, Schäffer J, Herden C, Pflieger FJ, Reiche S, Körber S, Kitagawa H, Welter J, Michels S, Culmsee C, Bier J, Sommer N, Kang JX, Mayer K, Hecker M, Rummel C. Hernandez J, et al. Among authors: welter j. Int J Mol Sci. 2023 Aug 31;24(17):13524. doi: 10.3390/ijms241713524. Int J Mol Sci. 2023. PMID: 37686333 Free PMC article.
170 results